نتائج البحث - "MESH: Lamivudine"

1

Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting

المؤلفون: Caroline Lions, N Biezunski, Sophie Matheron, Romain Guery, Pierre-Marie Roger, Caroline Charlier, Mathieu Dupont, Line Meddeb, Philippe Van de Perre, V Joly, R Lecomte, Matthieu Revest, Claudine Duvivier, B Lefèvre, M Delestan, H Laurichesse, H Marty, F Lemaitre, Martine Valette, Marc-Antoine Valantin, A S Ritleng, A Ménard, Eric Cua, M. Alvarez, A Raoux, M P Bouillon, A Sève, A Brebion, Claire Triffault-Fillit, Sylvie Bregigeon, M Carles, O. Aubry, S Hénard, P. Dellamonica, A Charmillon, E Alidjinou, V Brodard, M Tetart, F Raffi, Paul-Henri Consigny, O Lesens, C Brunet-Cartier, I Lamaury, S Giaché, Amandine Gagneux-Brunon, Jacques Reynes, Karine Sauné, Clotilde Allavena, Q Lepiller, Véronique Reliquet, C Louisin, I Perbost, Jean-Luc Berger, B Prouvost-Keller, Eric Delaporte, Isabelle Lamaury, C Gubavu, L Fagour, Laurent Cotte, G Gaube, Elina Teicher, Faouzi Souala, C Blanc, Dominique Merrien, Isabelle Poizot-Martin, C Drobacheff-Thiébaut, T May, P Richard, M A Trabaud, M Bistoquet, C Klotz, Samira Fafi-Kremer, M Marcel, Charlotte Charpentier, L Lelièvre, K Risso, Sandrine Pierre-François, S Ferrando, S Breaud, S Bevilacqua, A Montoya Ferrer, T Rojas-Rojas, D Boucher, Yazdan Yazdanpanah, Olivier Lortholary, Philippe Colson, Anne-Sophie Brunel, F-Xavier Lescure, Christelle Tomei, M Martin-Degioanni, Eric Rosenthal, Philippe Bossi, Patrick Miailhes, Kevin Bouiller, Lise Cuzin, A Foltzer, F Boulard, Michel Vidal, V Mondain, H Colson, J Pasquier, I Kmiec, F Alby-Laurent, R Agher, A Cabié, Guillaume Martin-Blondel, L Hocqueloux, M Colin, A Madrid, Faiza Ajana, J M Livrozet, V Rio, Karima Amazzough, C Merle de Boever, M Digumber, Thomas Perpoint, A Cheret, Laurence Bocket, Z Julia, Virginie Ferré, M Pradier, M Poisson-Vannier, A Legoff, M J Soavi, Y Quertainmont, Marine Morrier, Christian Chidiac, F Touam, O Zaegel-Faucher, A Marquise, G Benabdelmoumen, Florence Ader, T Guimard, M C Receveur, J C Tardy, P Morineau, K Guitteaud, D. Rey, S Leautez, Catherine Chirouze, Benoit Tressières, A. Ivanova, C Charre, J Reynes, Christian Pradier, Catherine Dhiver, Laurent Boyer, E Frentiu, David Rey, C Allavena, Anne Motte, Tristan Ferry, C Pronier, M. Hentzien, C Rouzaud, O Cabras, K Jidar, F Najioullah, C Clavel, M Orticoni, S Patrat-Delon, M Cavellec, Cécile Herrmann-Storck, V Baclet, Jade Ghosn, M Perry, S Wehrlen-Pugliese, J. M. Chapplain, R Palich, Laurent Hocqueloux, A Maillard, C Deschanvres, O Deradji, F. Lucht, A Grégoire, Veronique Joly, R Ouissa, C Daniel, N Mrozek, D Chirio, O Bollangier, J Bavay, P. Le Turnier, A Maka, C Rioux, Colin Deschanvres, C Brochier, Elisabeth Botelho-Nevers, A Meybeck, C Ceppi, J Lourenco, François Bénézit, Thomas Jovelin, G Zouzou, N Tissot, N. Viget, F Brunel-Dalmas, Brigitte Montes, N Chellum Rungen, K Rome, David Boutoille, B Bigeard, I Fabre, N Oran, M Lefebvre, P Point, C Etienne, Diane Descamps, G Thomas, S Le Gac, Cyrille Delpierre, Pierre Tattevin, M Godinot, P Fischer, C Aumeran, C Boulard, Elisabeth André-Garnier, J Sinteff, V Ronat, F Goehringer, Romain Palich, Luminita Schneider, I Touitou, Eric Billaud, P Thill, Catherine Varache, Olivier Robineau, I Jaquet, Roland Landman, Cédric Arvieux, B. Bonnet, V Rzepecki, Olivier Grossi, Christian Rabaud, L Laine, F Louni, C Cheneau, S Markowicz, Hélène Laroche, A Gervais, C Bernard-Henry, E Goncalvez, N Lerolle, M André, D Lambert, André Boibieux, L. Porte, S Bouchez, E Paredes, E Aïssi, V. Le Moing, S Degroodt, Sylvie Abel, André Cabié, B Lafon-Desmurs, O Babre, M Baldeyrou, C Debreux, A Rodallec, Pierre Delobel, V Icard, Agathe Becker, Edouard Tuaillon, Hervé Tissot-Dupont, M Mokhtari, C Morlat, I Alcaraz, Anne Frésard, O Cannesson, Elodie Curlier, P Chiarello, S. Roux, F Bani-Sadr, François Raffi, Florent Valour, M Piffaut, M Priester, A. Belkhir, J Romaru, Cécile Goujard, A Castro, G Cessot, A Mirand, C Pouderoux, A Brunet, C Michelangeli, Y N’guyen, Patrice Muret, Elisa Demonchy, Christine Jacomet, D Makhloufi, E Jeanmaire, Marialuisa Partisani, Véronique Obry-Roguet, J Turmel, C Mélounou, J. Durant, Christine Katlama, P Parize, O Robineau, S Seang, F. Bozon, S Galie, Alexa Debard, E de Mautort, C Duvivier, Fanny Lanternier, Alain Makinson, A Barrail-Tran, C Aguilar, A Naqvi, Rodolphe Garraffo, N Meftah, C Biron, A de Monte, Pascal Pugliese, V Corbin, S Jaureguiberry, E Lafont, L Hustache Mathieu, R Colarino, Isabelle Ravaux, C Henquell, Benoit Pilmis, M Grégoire, P Lansalot, E Ressiot, T. Huleux, Olivier Baud, S Sécher, R Dupin de Majoubert, J Leporrier, L Cuzin, E Chevalier, M Poinot, R Tubiana, S Lariven, A Boucher, N Atoui, Firouzé Bani-Sadr, T Prazuck, M Ducassou, Gilles Peytavin, A Soria, B J Gaborit

المساهمون: Service des maladies infectieuses et tropicales [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Dat’AIDS Study Group, Département Maladies Infectieuses et Tropicales, Hôpital Universitaire, Montpellier, France, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CHU Pointe-à-Pitre/Abymes [Guadeloupe], Les Hôptaux universitaires de Strasbourg (HUS), CHU Strasbourg, CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire de Reims (CHU Reims), Centre Hospitalier Gustave Dron [Tourcoing], Institut Pasteur [Paris] (IP), Centre Hospitalier Régional d'Orléans (CHRO), Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU de la Martinique [Fort de France], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], CHU Clermont-Ferrand, Université Clermont Auvergne (UCA)

المصدر: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 2022, 77 (1), pp.196-204. ⟨10.1093/jac/dkab367⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2021, 77 (1), pp.196-204. ⟨10.1093/jac/dkab367⟩

مصطلحات موضوعية: Microbiology (medical), medicine.medical_specialty, Anti-HIV Agents, Pyridones, MESH: Piperazines, HIV Infections, Emtricitabine, Piperazines, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Internal medicine, MESH: Pyridones, Oxazines, MESH: Emtricitabine, Humans, Medicine, Pharmacology (medical), MESH: Anti-HIV Agents, Pharmacology, MESH: Heterocyclic Compounds, 3-Ring, MESH: Humans, business.industry, Rilpivirine, Lamivudine, MESH: HIV Infections, Viral Load, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, Virological failure, Regimen, Infectious Diseases, chemistry, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Dolutegravir, Cohort, MESH: Rilpivirine, business, MESH: Viral Load, Heterocyclic Compounds, 3-Ring, MESH: Oxazines, medicine.drug, MESH: Lamivudine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033c18957dab579ab7bad3465386ebf0
https://hal.science/hal-03640621

2

Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery

المؤلفون: Patumrat Sripan, Saik Urien, Billy Amzal, Thitiporn Siriwachirachai, P. Kanjanavikai, Gonzague Jourdain, P. Sabsanong, Suporn Koetsawang, Tim R. Cressey, Sophie Le Coeur, Marc Lallemant, Tapnarong Jarupanich, Boonsong Rawangban, Virat Klinbuayaem, Nicole Ngo-Giang-Huong, Phpt site investigators, Phaiboon Wanasiri

المساهمون: Drugs for Neglected Diseases Initiative, Certara, Institut de Recherche pour le Développement (IRD), Infections à Vih, Réservoirs, Pharmacologie des Antirétroviraux et Prévention de la Transmission Mère Enfant, Université Paris Descartes - Paris 5 (UPD5), Épidémiologie clinique, santé mère-enfant et VIH en Asie du Sud-Est (IRD_PHPT), Harvard University [Cambridge]-Chiang Mai University (CMU), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Institut national d'études démographiques (INED)

المصدر: J Acquir Immune Defic Syndr
Journal of Acquired Immune Deficiency Syndromes
Journal of Acquired Immune Deficiency Syndromes, Lippincott, Williams & Wilkins, 2020, 84 (3), pp.313-322. ⟨10.1097/QAI.0000000000002350⟩
Journal of Acquired Immune Deficiency Syndromes, Lippincott, Williams & Wilkins, 2020, ⟨10.1097/QAI.0000000000002350⟩

مصطلحات موضوعية: prevention of mother-to-child transmission, HIV Infections, 030312 virology, [SHS]Humanities and Social Sciences, MESH: Pregnancy, Pregnancy, Pharmacology (medical), Young adult, MESH: Anti-HIV Agents, MESH: Nevirapine, Pregnancy Complications, Infectious, 0303 health sciences, Transmission (medicine), Obstetrics, MESH: Infant, Newborn, virus diseases, MESH: Zidovudine, clinical trial, Lopinavir, MESH: HIV Infections, Viral Load, Thailand, historical control, MESH: Mothers, 3. Good health, MESH: Infectious Disease Transmission, Vertical, Drug Combinations, Infectious Diseases, MESH: Young Adult, Lamivudine, Female, MESH: Viral Load, Viral load, Zidovudine, medicine.drug, MESH: Lamivudine, Adult, medicine.medical_specialty, Nevirapine, Anti-HIV Agents, MESH: Bayes Theorem, antiretroviral therapy, education, Mothers, Bayesian design, Article, 03 medical and health sciences, Young Adult, medicine, Humans, intrapartum transmission, MESH: Pregnancy Complications, Infectious, MESH: Thailand, MESH: Drug Combinations, MESH: Humans, business.industry, Infant, Newborn, HIV, MESH: Adult, Bayes Theorem, medicine.disease, Infectious Disease Transmission, Vertical, meta-analysis, Regimen, business, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de12d84e419aca3fd9c783f7e106e152
https://pubmed.ncbi.nlm.nih.gov/32205720

3

Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

المساهمون: University of Manchester [Manchester], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Necker - Enfants Malades [AP-HP], Université Paris Descartes - Paris 5 (UPD5), Institut Pasteur [Paris] (IP), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Université de Lyon, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université de Liège, CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois], AP-HP Hôpital universitaire Robert-Debré [Paris], Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Robert Debré, Sorbonne Université (SU), University of Edinburgh, Supported by grants from the European Leukodystrophy Association (ELA 2012-008l1), the European Research Council (GA 309449 and 786142-E-T1IFNs), ERA-NET Neuron (MR/M501803/1), and the French National Research Agency (ANR-10-IAHU-01 and CE17001002). Medications were provided by GlaxoSmithKline and ViiV Healthcare., ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010), European Project: 309449,EC:FP7:ERC,ERC-2012-StG_20111109,T1-IFN(2013), Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques (LCBPT - UMR 8601), Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Institut Pasteur [Paris], CHU Toulouse [Toulouse], Vougny, Marie-Christine, Instituts Hospitalo-Universitaires - Institut Hospitalo-Universitaire Imagine - - Imagine2010 - ANR-10-IAHU-0001 - IAHU - VALID, Definition and characterization of type I interferonopathies - T1-IFN - - EC:FP7:ERC2013-03-01 - 2018-02-28 - 309449 - VALID

المصدر: New England Journal of Medicine
New England Journal of Medicine, 2018, 379 (23), pp.2275-2277. ⟨10.1056/NEJMc1810983⟩
Rice, G I, Meyzer, C, Bouazza, N, Hully, M, Boddaert, N, Semeraro, M, Zeef, L A H, Rozenberg, F, Bondet, V, Duffy, D, Llibre, A, Baek, J, Sambe, M N, Henry, E, Jolaine, V, Barnerias, C, Barth, M, Belot, A, Cances, C, Debray, F-G, Doummar, D, Frémond, M-L, Kitabayashi, N, Lepelley, A, Levrat, V, Melki, I, Meyer, P, Nougues, M-C, Renaldo, F, Rodero, M P, Rodriguez, D, Roubertie, A, Seabra, L, Uggenti, C, Abdoul, H, Treluyer, J-M, Desguerre, I, Blanche, S & Crow, Y J 2018, ' Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome ', New England Journal of Medicine, vol. 379, no. 23, pp. 2275-7 . https://doi.org/10.1056/NEJMc1810983
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (23), pp.2275-2277. ⟨10.1056/NEJMC1810983⟩
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (23), pp.2275-2277. ⟨10.1056/NEJMc1810983⟩

مصطلحات موضوعية: 0301 basic medicine, [SDV]Life Sciences [q-bio], Gene Expression, Pilot Projects, Nervous System Malformations/drug therapy, Medicine, MESH: Interferons, ComputingMilieux_MISCELLANEOUS, Cerebrovascular Circulation/drug effects, MESH: Zidovudine, General Medicine, MESH: Cerebrovascular Circulation, 3. Good health, Drug Combinations, MESH: Dideoxynucleosides, Lamivudine, Cerebrovascular Circulation, Autoimmune Diseases of the Nervous System/drug therapy, Reverse Transcriptase Inhibitors, [SDV.IMM]Life Sciences [q-bio]/Immunology, France, Zidovudine, MESH: Lamivudine, Interferons/genetics, Reverse Transcriptase Inhibitors/therapeutic use, MESH: Gene Expression, [SDV.IMM] Life Sciences [q-bio]/Immunology, Zidovudine/therapeutic use, Encephalopathy, Gene Expression/drug effects, Nervous System Malformations, MESH: Nervous System Malformations, 03 medical and health sciences, Autoimmune Diseases of the Nervous System, Humans, Lamivudine/therapeutic use, MESH: Drug Combinations, MESH: Humans, business.industry, Dideoxynucleosides/therapeutic use, medicine.disease, MESH: Pilot Projects, Virology, Dideoxynucleosides, Reverse transcriptase, MESH: Autoimmune Diseases of the Nervous System, MESH: France, 030104 developmental biology, Nucleic acid, Aicardi–Goutières syndrome, Interferons, MESH: Reverse Transcriptase Inhibitors, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::771251eb6b388f0e1e12dad20dec87f3

Find this article in full text from ProQuest

4

High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients

المؤلفون: Clotilde Allavena, Marie-Paule Schmitt, Bruno Hoen, Pascal Chavanet, P. Meyer, Michel Duong, J. M. Lang, David Rey, M. Diemer, Thierry May, Vincent Calvez, Bruno Spire, G. Hoizey, Gilles Peytavin, J. L. Schmit

المساهمون: Entente Interdépartementale pour la Démoustication, Région Rhône-Alpes, Service des maladies infectieuses et tropicales, Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Hôpital Saint-Jacques, Laboratoire Chrono-environnement ( LCE ), Université Bourgogne Franche-Comté ( UBFC ) -Centre National de la Recherche Scientifique ( CNRS ) -Université de Franche-Comté ( UFC ), Institut de Recherches sur les lois Fondamentales de l'Univers ( IRFU ), Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Université Paris-Saclay, Laboratoire du Service d'Oncologie Médicale, Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Pitié-Salpêtrière [APHP], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Hôpital Saint-Jacques, Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Institut de Recherches sur les lois Fondamentales de l'Univers (IRFU), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire Chrono-environnement (UMR 6249) (LCE), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)

المصدر: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2009, 63 (2), pp.380-8. 〈10.1093/jac/dkn471〉
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2009, 63 (2), pp.380-8. ⟨10.1093/jac/dkn471⟩
Journal of Antimicrobial Chemotherapy, 2009, 63 (2), pp.380-8. ⟨10.1093/jac/dkn471⟩

مصطلحات موضوعية: Male, MESH: CD4 Lymphocyte Count, HIV Infections, MESH : Viral Load, Gastroenterology, MESH: HIV-1, MESH : Adenine, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH : Female, Pharmacology (medical), 030212 general & internal medicine, MESH: Nevirapine, MESH: Anti-HIV Agents, MESH : Viral Proteins, MESH: Treatment Outcome, 0303 health sciences, MESH: Middle Aged, MESH: Drug Resistance, Viral, Reverse-transcriptase inhibitor, MESH : Lamivudine, Lamivudine, MESH: HIV Infections, Middle Aged, Viral Load, MESH : Adult, Resistance mutation, MESH: Amino Acid Substitution, 3. Good health, MESH : Drug Resistance, Viral, [ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Treatment Outcome, Infectious Diseases, Female, Viral disease, MESH: Viral Load, MESH : Phosphonic Acids, MESH : HIV-1, MESH: Lamivudine, medicine.drug, Adult, Microbiology (medical), medicine.medical_specialty, MESH: Adenine, Nevirapine, Anti-HIV Agents, MESH : Male, MESH : Nevirapine, Mutation, Missense, Organophosphonates, MESH: Phosphonic Acids, MESH : Treatment Outcome, Biology, Viral Proteins, 03 medical and health sciences, Zidovudine, MESH : Amino Acid Substitution, Internal medicine, Drug Resistance, Viral, MESH : CD4 Lymphocyte Count, MESH : HIV Infections, medicine, Humans, MESH : Middle Aged, Tenofovir, Pharmacology, MESH: Mutation, Missense, MESH: Humans, 030306 microbiology, Adenine, MESH : Anti-HIV Agents, MESH : Humans, MESH: Adult, Interim analysis, MESH: Viral Proteins, Virology, MESH: Male, CD4 Lymphocyte Count, Regimen, Amino Acid Substitution, HIV-1, MESH: Female, MESH : Mutation, Missense

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bacc2bb8c1c0301b738bdcefff0f5885
https://doi.org/10.1093/jac/dkn471

5

Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART

المؤلفون: Panhard, Xavière, Legrand, Mayeule, Taburet, Anne-Marie, Diquet, Bertrand, Goujard, Cécile, Mentré, France, Anrs 102 Study Group, Cophar 1

المساهمون: Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques (U738 / UMR_S738), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Département d'épidémiologie, biostatistique et recherche clinique, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de pharmacie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, Département de Pharmacologie-Toxicologie [CHU Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Service de médecine interne et maladies infectieuses, Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Comets, Emmanuelle

المصدر: European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, Springer Verlag, 2007, 63 (11), pp.1019-29. ⟨10.1007/s00228-007-0337-x⟩

مصطلحات موضوعية: Male, MESH: Drug Interactions, HIV Infections, Indinavir, Pharmacology, 030226 pharmacology & pharmacy, MESH: Antiretroviral Therapy, Highly Active, 0302 clinical medicine, Antiretroviral Therapy, Highly Active, Drug Interactions, Tissue Distribution, Pharmacology (medical), Population pharmacokinetics, MESH: Anti-HIV Agents, [INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM], MESH: Aged, Volume of distribution, 0303 health sciences, education.field_of_study, [SDV.BIBS] Life Sciences [q-bio]/Quantitative Methods [q-bio.QM], Nelfinavir, MESH: Middle Aged, Stavudine, MESH: Zidovudine, Lamivudine, MESH: HIV Infections, General Medicine, Middle Aged, [SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM], 3. Good health, Reverse Transcriptase Inhibitors, Nucleoside analogs, Female, Zidovudine, MESH: Lamivudine, medicine.drug, Adult, Anti-HIV Agents, MESH: Nelfinavir, Population, MESH: Stavudine, Biology, Models, Biological, Article, 03 medical and health sciences, Pharmacokinetics, medicine, Humans, Drug-drug interactions, MESH: Tissue Distribution, education, Aged, MESH: Humans, 030306 microbiology, MESH: Indinavir, MESH: Models, Biological, MESH: Adult, MESH: Male, MESH: Reverse Transcriptase Inhibitors, [INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM], MESH: Female

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa9e8b4e2ab0aec2e42738243b70c40
https://doi.org/10.1007/s00228-007-0337-x

Find this article in full text from ProQuest

6

Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs

المؤلفون: Nathalie Dejucq-Rainsford, Roger Le Grand, Anna Le Tortorec, Nathalie Deureuddre-Bosquet, Marina Moreau, Claire Deleage, Olivier Bourry, Hélène Denis, Charles C. Brown, Pierre Roques, Anne-Pascale Satie

المساهمون: Environnement viral et chimique & reproduction, Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Laboratory of Molecular Microbiology, National Institute of Allergy and Infections Diseases-National Institutes of Health, Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Institut des Maladies Emergentes et des Thérapies Innovantes (IMETI), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Le Corre, Morgane, Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA)

المصدر: PLoS ONE, Vol 7, Iss 5, p e37348 (2012)
PLoS ONE
PLoS ONE, 2012, 7 (5), pp.e37348. ⟨10.1371/journal.pone.0037348⟩
PLoS ONE, Public Library of Science, 2012, 7 (5), pp.e37348. ⟨10.1371/journal.pone.0037348⟩

مصطلحات موضوعية: Male, Simian Acquired Immunodeficiency Syndrome, lcsh:Medicine, Indinavir, medicine.disease_cause, MESH: Antiretroviral Therapy, Highly Active, Immunodeficiency Viruses, MESH: Genitalia, Male, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Antiretroviral Therapy, Highly Active, MESH: Animals, lcsh:Science, 0303 health sciences, Multidisciplinary, Lamivudine, MESH: Zidovudine, virus diseases, HIV diagnosis and management, Animal Models, Viral Load, Antivirals, Viral Persistence and Latency, 3. Good health, Host-Pathogen Interaction, MESH: RNA, Viral, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Medicine, Infectious diseases, RNA, Viral, Simian Immunodeficiency Virus, medicine.symptom, MESH: Simian Acquired Immunodeficiency Syndrome, MESH: Viral Load, Zidovudine, Viral load, Macaque, Research Article, medicine.drug, MESH: Lamivudine, MESH: Simian immunodeficiency virus, Retrovirology and HIV immunopathogenesis, Semen, Viral diseases, Genitalia, Male, Biology, Microbiology, Asymptomatic, 03 medical and health sciences, Model Organisms, Virology, medicine, Animals, Sex organ, MESH: Semen, 030304 developmental biology, 030306 microbiology, MESH: Indinavir, lcsh:R, HIV, Simian immunodeficiency virus, MESH: Male, Animal Models of Infection, Macaca fascicularis, MESH: Macaca fascicularis, Immunology, lcsh:Q, Viral Transmission and Infection

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aed6118c2c5de292f90c7f426d34022
http://europepmc.org/articles/PMC3355136?pdf=render

Find this article in full text from ProQuest

7

Hepatitis B virus resistance to antiviral drugs: where are we going?

المؤلفون: Zoulim, Fabien

المساهمون: Zoulim, Fabien, Service d'hépatologie et de gastroentérologie, Hospices Civils de Lyon (HCL)-Hôtel-Dieu, Physiopathologie moléculaire et nouveaux traitements des hépatites virales, Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-IFR62-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Liver International
Liver International, Wiley-Blackwell, 2011, 31 Suppl 1, pp.111-6. ⟨10.1111/j.1478-3231.2010.02399.x⟩

مصطلحات موضوعية: MESH: Antiviral Agents, Hepatitis B virus, Guanine, MESH: Adenine, MESH: Hepatitis B, Chronic, MESH: Virus Internalization, Organophosphonates, MESH: Phosphonic Acids, MESH: Pyrimidinones, Pyrimidinones, Virus Replication, Antiviral Agents, Article, MESH: Clinical Protocols, Capsid, Hepatitis B, Chronic, Clinical Protocols, Drug Resistance, Viral, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, Humans, MESH: Capsid, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, MESH: Nucleosides, Chronic hepatitis, MESH: Guanine, Telbivudine, MESH: Drug Resistance, Viral, MESH: Humans, Adenine, MESH: Virus Replication, Nucleosides, interferon, Virus Internalization, Antivirals, tenofovir, MESH: Hepatitis B virus, Lamivudine, Drug resistance, Thymidine, entecavir, MESH: Lamivudine

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9457ec76e2be5aada526f03a5e009b0f
https://doi.org/10.1111/j.1478-3231.2010.02399.x

View record at Wiley

8

Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion

المؤلفون: Roger Le Grand, Olivier Bourry, Nathalie Dereuddre-Bosquet, Lucie Durand-Gasselin, Abdelkrim Mannioui, Henri Benech, Pierre Sellier, Camille Roucairol, Pierre Roques

المساهمون: Institut des Maladies Emergentes et des Thérapies Innovantes (IMETI), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Groupe d'Etude de la Reproduction Chez l'Homme et les Mammiferes (GERHM), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Lariboisière, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Service de Pharmacologie et Immunoanalyse (SPI), Médicaments et Technologies pour la Santé (MTS), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), BMC, Ed.

المصدر: Retrovirology
Retrovirology, BioMed Central, 2010, 7 (1), pp.78. ⟨10.1186/1742-4690-7-78⟩
Retrovirology, 2010, 7 (1), pp.78. ⟨10.1186/1742-4690-7-78⟩
Retrovirology, Vol 7, Iss 1, p 78 (2010)

مصطلحات موضوعية: Male, Time Factors, Simian Acquired Immunodeficiency Syndrome, Administration, Oral, Indinavir, medicine.disease_cause, MESH: Antiretroviral Therapy, Highly Active, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Antiretroviral Therapy, Highly Active, Tissue Distribution, MESH: Animals, 030212 general & internal medicine, 0303 health sciences, virus diseases, MESH: Zidovudine, MESH: Administration, Cutaneous, 3. Good health, Infectious Diseases, Lamivudine, MESH: Administration, Oral, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Reverse Transcriptase Inhibitors, Simian Immunodeficiency Virus, MESH: Simian Acquired Immunodeficiency Syndrome, Zidovudine, medicine.drug, MESH: Lamivudine, lcsh:Immunologic diseases. Allergy, MESH: Simian immunodeficiency virus, medicine.drug_class, Viremia, Context (language use), Biology, MESH: Drug Administration Schedule, Administration, Cutaneous, Virus, Drug Administration Schedule, 03 medical and health sciences, Virology, medicine, Animals, MESH: Tissue Distribution, MESH: Viremia, 030304 developmental biology, MESH: HIV Protease Inhibitors, Research, MESH: Indinavir, MESH: Time Factors, HIV Protease Inhibitors, Simian immunodeficiency virus, medicine.disease, MESH: Male, Chronic infection, Macaca fascicularis, Viral replication, MESH: Macaca fascicularis, Immunology, Antiviral drug, MESH: Reverse Transcriptase Inhibitors, lcsh:RC581-607

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::541b3ee56074bd3fdbafd17474c70b82
https://www.hal.inserm.fr/inserm-00668445/document

Find this article in full text from ProQuest

9

A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients

المؤلفون: Pierre-Marie, Girard, André, Cabié, Christian, Michelet, Renaud, Verdon, Christine, Katlama, Patrick, Mercié, Laurence, Morand-Joubert, Pascal, Pétour, Françoise, Monchecourt, Geneviève, Chêne, Aldo, Trylesinski, D, Zucman

المساهمون: Services des Maladies Infectieuses et Tropicales [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service des maladies infectieuses et réanimation médicale [Rennes] = Infectious Disease and Intensive Care [Rennes], CHU Pontchaillou [Rennes], Signalisation et Réponses aux Agents Infectieux et Chimiques (SeRAIC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Unité de Maladies Infectieuses et Tropicales [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Service des maladies infectieuses et tropicales [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Epidémiologie et Biostatistique [Bordeaux], Université Bordeaux Segalen - Bordeaux 2-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH), CHU Bordeaux [Bordeaux], Service de médecine interne et maladies infectieuses [Bordeaux], CHU Bordeaux [Bordeaux]-Groupe hospitalier Saint-André, Service de bactériologie-virologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Gilead Sciences, Epidémiologie, santé publique et développement, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR99-ISPED, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Rennes (UR)

المصدر: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2009, 64 (1), pp.126-34. ⟨10.1093/jac/dkp141⟩
Journal of Antimicrobial Chemotherapy, 2009, 64 (1), pp.126-34. ⟨10.1093/jac/dkp141⟩

مصطلحات موضوعية: Cyclopropanes, Male, MESH: CD4 Lymphocyte Count, HIV Infections, MESH: Antiretroviral Therapy, Highly Active, law.invention, MESH: HIV-1, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Antiretroviral Therapy, Highly Active, Pharmacology (medical), 030212 general & internal medicine, MESH: Anti-HIV Agents, MESH: Treatment Outcome, 0303 health sciences, MESH: Middle Aged, Reverse-transcriptase inhibitor, lipid abnormalities, Lamivudine, MESH: HIV Infections, Middle Aged, Viral Load, 3. Good health, Infectious Diseases, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Treatment Outcome, MESH: Benzoxazines, Alkynes, Female, France, MESH: Viral Load, medicine.drug, MESH: Lamivudine, Microbiology (medical), Adult, medicine.medical_specialty, Efavirenz, MESH: Adenine, Anti-HIV Agents, Organophosphonates, MESH: Phosphonic Acids, Biology, 03 medical and health sciences, Internal medicine, medicine, Humans, HIV-1 RNA, Adverse effect, Tenofovir, Pharmacology, Intention-to-treat analysis, MESH: Humans, 030306 microbiology, CD4 T lymphocytes, simplification therapy, Adenine, MESH: Adult, HIV infection, Confidence interval, MESH: Male, Benzoxazines, CD4 Lymphocyte Count, MESH: France, Regimen, chemistry, Immunology, HIV-1, MESH: Female

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a617e4e6cd11f42ccaef14edaa8b2582
https://pubmed.ncbi.nlm.nih.gov/19403652

10

Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy

المؤلفون: Georges Herbein, Clément Prati, Eric Toussirot, Vincent Di Martino, Daniel Wendling

المساهمون: Service de Rhumatologie, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Service d'Hépato-Gastro-Entérologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Agents pathogènes et inflammation - UFC (EA 4266) (API), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)

المصدر: Joint Bone Spine
Joint Bone Spine, Elsevier Masson, 2009, 76 (3), pp.308-11. ⟨10.1016/j.jbspin.2008.11.005⟩

مصطلحات موضوعية: Male, MESH: Antirheumatic Agents, medicine.disease_cause, Receptors, Tumor Necrosis Factor, Etanercept, MESH: Antibodies, Monoclonal, MESH: Virus Activation, 0302 clinical medicine, MESH: Immunocompromised Host, MESH: Treatment Outcome, MESH: Immunoglobulin G, Antibodies, Monoclonal, Lamivudine, Viral Load, Hepatitis B, 3. Good health, MESH: Hepatitis B virus, Treatment Outcome, MESH: Methotrexate, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Antirheumatic Agents, Drug Therapy, Combination, Female, 030211 gastroenterology & hepatology, Tumor necrosis factor alpha, MESH: Viral Load, Viral load, MESH: Spondylarthropathies, medicine.drug, MESH: Lamivudine, Adult, MESH: Antiviral Agents, Hepatitis B virus, MESH: Adenine, MESH: Hepatitis B, Chronic, Organophosphonates, MESH: Phosphonic Acids, Antiviral Agents, Immunocompromised Host, 03 medical and health sciences, Hepatitis B, Chronic, Rheumatology, medicine, Humans, 030203 arthritis & rheumatology, Hepatitis, MESH: Humans, Tumor Necrosis Factor-alpha, business.industry, Adenine, Antagonist, MESH: Adult, medicine.disease, MESH: Receptors, Tumor Necrosis Factor, Infliximab, MESH: Male, MESH: Drug Therapy, Combination, Methotrexate, Immunoglobulin G, MESH: Tumor Necrosis Factor-alpha, Immunology, Spondylarthropathies, Virus Activation, business, MESH: Female

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4015a046438a3a3227e4a45f69533fc8
https://hal.archives-ouvertes.fr/hal-00464766

View record from ScienceDirect

Full Text via ClinicalKey

تنقيح النتائج